| AUC | Area under the ROC curve |
| Bz-PFR-pNA | N-benzoyl-Pro-Phe-Arg-p-nitroanilide hydrochloride |
| CD | Chagas disease |
| cTXNPx | Cytoplasmic tryparedoxin peroxidase |
| CZP | Cruzipain |
| CZP-TSC | Cruzipain-thiosemicarbazone adduct |
| DMSO | Dimethyl sulfoxide |
| DTT | Dithiothreitol |
| E64 inhibitor | N-[n-(l-3-trans-carboxyoxirane-2-carbonyl)-l-leucyl]-agmatine |
| EC50 | Concentration of the compounded needed to induce a 50% response |
| FBS | Fetal bovine serum |
| GAFF2 | General Amber force field, second generation |
| GSH | Glutathione |
| IMAC | Immobilized metal affinity chromatography |
| MACCS | Molecular access system fingerprint |
| MD | Molecular dynamics simulation |
| MM/PB(GB)SA | Molecular mechanics with Poisson-Boltzmann (PB) or Generalized Born (GB) surface area solvation |
| MM-GBSA | Molecular mechanics with Generalized Born and surface area solvation |
| MS | Mass spectrometry |
| NADPH | Reduced nicotinamide adenine dinucleotide phosphate |
| NHDF | Normal human dermal fibroblasts |
| NMR | Nuclear magnetic resonance |
| NPT | Constant number of particles, pressure, and temperature |
| NVT | Constant number of particles, volume, and temperature |
| RMSD | Root mean square deviation |
| ROC | Receiver Operating Characteristic |
| SAR | Structure-activity relationships |
| SASA | Solvent-accessible surface area |
| SMILES | Simplified molecular input line entry system |
| T. cruzi | Trypanosoma cruzi |
| Ta | Tanimoto similarity analysis |
| t-BuOOH | Tert-butyl hydroperoxide |
| TcGPx-I | T. cruzi glutathione peroxidase type I |
| TcTR | T. cruzi trypanothione reductase |
| TSC | Thiosemicarbazone |
| TXN | Tryparedoxin |
| TXN-I | Tryparedoxin 1 |
| ΔGbinding | Binding free energy |
| ΔGR | R-pose binding free energy |
| ΔGS | S-pose binding free energy |